6-August-2019: The global embolic
protection devices market size is expected to reach USD
1.7 billion by 2026, according to a new report by Grand View Research, Inc. The
market is estimated to expand at a CAGR of 8.4% during the forecast period.
Rising incidences of cardiovascular and neurovascular diseases and growing
adoption of minimally invasive diseases are propelling the market growth.
Rising demand for technologically advanced embolic devices and increasing
healthcare expenditure, resulting in huge funding and investments from
multinational companies, are fueling the R&D in the global medical devices
industry. This factor is also contributing toward the market growth.
On the other hand,
the product failures and recalls may limit the market growth. Low reimbursement
for stenting and presence of alternative treatment methods, such as the use of
drugs, may also imped the market development. However, factors such as a rise in
the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will
support the market expansion. The number of TAVR centers in U.S. has increased
from 156 in 2012 to 511 in 2017, and approximately 35,000 patients underwent
TAVR in 2016 in U.S. alone. The distal occlusion systems segment is expected to
register the highest CAGR over the forecast period.
In
depth research report on Embolic Protection Devices Market
Further key findings from the study suggest:
·
Distal filter devices segment emerged as the largest segment
owing to high demand for these devices
·
Neurovascular diseases accounted for the largest share in the
application segment owing to the rising cases of neurological disorders
·
North America led the global embolic protection devices
market with the largest share in 2017 and is likely to maintain this trend over
the estimated period
·
Growing adoption of minimally invasive surgeries and
increasing demand for novel technologies are facilitating the dominance of this
region
·
The industry in the Asia Pacific is projected to witness
swift growth during the forecast period owing to rapidly improving healthcare
infrastructure and large target population base
·
Some of the key companies include Boston Scientific Corp.;
Edward Lifesciences; Abbott Laboratories; Medtronic Plc; Cardinal Health, Inc.;
Claret Medical, Inc.; and Innovative Cardiovascular Solutions, LLC
Grand View Research
has segmented the global embolic protection devices market on the basis of
product, application, and region:
Embolic Protection Devices Product Outlook (Revenue, USD
Million, 2014 - 2026)
·
Distal Occlusion Devices
·
Proximal Occlusion Devices
·
Distal Filters
Embolic Protection Devices Application Outlook (Revenue, USD
Million, 2014 - 2026)
·
Neurovascular Diseases
·
Cardiovascular Diseases
·
Peripheral Vascular Diseases
Browse
more research reports of this category:
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment